anmelden
FTSE All-Share
5.735,46
PKT
+15,93
PKT
+0,28
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.05.21 | AstraZeneca buy | UBS AG | |
| 06.05.21 | Prudential Outperform | Credit Suisse Group | |
| 06.05.21 | National Grid buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.05.21 | HSBC buy | Goldman Sachs Group Inc. | |
| 05.05.21 | Barclays buy | UBS AG | |
| 04.05.21 | Barclays overweight | JP Morgan Chase & Co. | |
| 04.05.21 | Barclays Outperform | Credit Suisse Group | |
| 04.05.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 04.05.21 | Unilever buy | Deutsche Bank AG | |
| 04.05.21 | AstraZeneca buy | Deutsche Bank AG | |
| 04.05.21 | Barclays buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.05.21 | Unilever Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.05.21 | Barclays Outperform | Credit Suisse Group | |
| 03.05.21 | AstraZeneca buy | Kepler Cheuvreux | |
| 03.05.21 | AstraZeneca Verkaufen | DZ BANK | |
| 03.05.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 03.05.21 | Barclays buy | Goldman Sachs Group Inc. | |
| 30.04.21 | Barclays buy | UBS AG | |
| 30.04.21 | Unilever Neutral | JP Morgan Chase & Co. | |
| 30.04.21 | AstraZeneca buy | UBS AG | |
| 30.04.21 | Barclays Sector Perform | RBC Capital Markets | |
| 30.04.21 | National Grid buy | UBS AG | |
| 30.04.21 | Prudential Neutral | JP Morgan Chase & Co. | |
| 30.04.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 30.04.21 | Unilever buy | Jefferies & Company Inc. | |
| 30.04.21 | Shell (ex Royal Dutch Shell) buy | Jefferies & Company Inc. | |
| 30.04.21 | AstraZeneca buy | Jefferies & Company Inc. | |
| 30.04.21 | Barclays buy | Jefferies & Company Inc. | |
| 30.04.21 | Unilever buy | Deutsche Bank AG | |
| 30.04.21 | Shell (ex Royal Dutch Shell) buy | Deutsche Bank AG | |
| 30.04.21 | GSK Sell | Deutsche Bank AG | |
| 30.04.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.04.21 | Barclays buy | Goldman Sachs Group Inc. | |
| 30.04.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.04.21 | Barclays overweight | JP Morgan Chase & Co. | |
| 30.04.21 | Shell (ex Royal Dutch Shell) Equal weight | Barclays Capital | |
| 30.04.21 | Shell (ex Royal Dutch Shell) Equal weight | Barclays Capital | |
| 30.04.21 | BP overweight | Barclays Capital | |
| 30.04.21 | Unilever buy | Goldman Sachs Group Inc. | |
| 29.04.21 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. |